Clinical trial
Multicenter Trial For Patients With Acute Crohn's Disease
NCT00035503 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Completed
Key facts
| NCT number | NCT00035503 |
|---|---|
| Title | Multicenter Trial For Patients With Acute Crohn's Disease |
| Lead sponsor | Teva Branded Pharmaceutical Products R&D, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | etiprednol dicloacetate |
| Start date | Jan 31, 2002 |
| Primary completion | Jan 31, 2004 |
| Completion | Jan 31, 2004 |
| First posted | May 6, 2002 |
| Last update posted | Dec 8, 2021 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: